MedTrace Logo

Africa and Middle East Cardiovascular Epidemiological Study

NCT01243138 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 4386

Last updated 2021-02-18

No results posted yet for this study

Summary

This is a cross-sectional, epidemiological study to determine the prevalence of cardiovascular risk factors such as obesity, smoking, dyslipidemia, diabetes mellitus and hypertension in patients attending General Practice clinics in the Africa and Middle East region. A total of 4300 patients will be evaluated. In patients who are found to have previously been diagnosed with cardiovascular (CV) risk factors such as dyslipidemia or hypertension, the level of control of their respective conditions will also be evaluated.

Conditions

Sponsors & Collaborators

  • Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

    lead INDUSTRY

Principal Investigators

  • Pfizer CT.gov Call Center · Pfizer

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-07-31
Primary Completion
2012-04-30
Completion
2012-04-30

Countries

  • Algeria
  • Cameroon
  • Egypt
  • Ghana
  • Jordan
  • Kenya
  • Kuwait
  • Lebanon
  • Nigeria
  • Saudi Arabia
  • Senegal
  • South Africa
  • Tunisia
  • United Arab Emirates

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01243138 on ClinicalTrials.gov